Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
NYSE: BHVN · IEX Real-Time Price · USD
34.17
-1.14 (-3.23%)
At close: Jul 2, 2024, 4:00 PM
34.16
-0.01 (-0.03%)
After-hours: Jul 2, 2024, 7:05 PM EDT
BHVN Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
239
Market Cap
3.02B USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 0 | - | - |
| Dec 31, 2022 | 0 | - | - |
| Dec 31, 2021 | 0 | - | - |
| Dec 31, 2020 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBHVN News
- 4 weeks ago - Biohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas including Immunology, Neuroscience, Metabolic Disorders and Oncology at Annual Investor R&D Day - PRNewsWire
- 4 weeks ago - Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors - PRNewsWire
- 7 weeks ago - Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments - PRNewsWire
- 2 months ago - Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - PRNewsWire
- 2 months ago - Biohaven Announces Pricing of $230 Million Public Offering of Common Shares - PRNewsWire
- 2 months ago - Biohaven Announces Proposed Public Offering of Common Shares - PRNewsWire
- 2 months ago - Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates - PRNewsWire
- 4 months ago - Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments - PRNewsWire